IPH LIMITED (IPH)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

IPH - IPH LIMITED

FNArena Sector : Legal
Year End: June
GICS Industry Group : Commercial & Professional Services
Debt/EBITDA: 2.68
Index: ASX200 | ASX300 | ALL-ORDS

IPH Ltd is Australia's largest intellectual property services company providing protection, commercialisation and management of intellectual property. It has been a listed company since 2014.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$6.21

12 Apr
2024

0.310

OPEN

$5.86

5.25%

HIGH

$6.21

1,299,216

LOW

$5.86

TARGET
$8.913 43.5% upside
Franking for last dividend paid out: 35%
OTHER COMPANIES IN THE SAME SECTOR
QIP . SHJ .
FNARENA'S MARKET CONSENSUS FORECASTS
IPH: 1
Title FY22
Actual
FY23
Actual
FY24
Forecast
FY25
Forecast
EPS (cps) xxx N/A 45.4 xxx
DPS (cps) xxx N/A 34.8 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A 13.4 xxx
Dividend Yield xxx N/A 5.7% xxx
Div Pay Ratio(%) xxx N/A 76.8% xxx

Dividend yield today if purchased 3 years ago: 4.49%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

5.43

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 27/02 - ex-div 16c (franking 35%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx28.6
DPS All xxxxxxxxxxxxxxx33.0
Sales/Revenue xxxxxxxxxxxxxxx482.9 M
Book Value Per Share xxxxxxxxxxxxxxx247.4
Net Operating Cash Flow xxxxxxxxxxxxxxx91.8 M
Net Profit Margin xxxxxxxxxxxxxxx13.37 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx12.82 %
Return on Invested Capital xxxxxxxxxxxxxxx8.13 %
Return on Assets xxxxxxxxxxxxxxx6.85 %
Return on Equity xxxxxxxxxxxxxxx12.82 %
Return on Total Capital xxxxxxxxxxxxxxx13.80 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx32.1 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx10 M
Long Term Debt xxxxxxxxxxxxxxx432 M
Total Debt xxxxxxxxxxxxxxx441 M
Goodwill - Gross xxxxxxxxxxxxxxx508 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx103 M
Price To Book Value xxxxxxxxxxxxxxx3.17

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx6.9 M
Capex % of Sales xxxxxxxxxxxxxxx1.43 %
Cost of Goods Sold xxxxxxxxxxxxxxx-
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx318 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx6 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

4
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgans

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

23/02/2024

1

Buy

$8.50

36.88%

IPH Ltd's H1 report positively surprised on multiple metrics, operational cash flows in particular, but equally showed multiple disappointments, including soft revenues from the Asian region as one large client in China exited while the market in Singapore proved weaker generally.

UBS sees IPH's market share stabilising in A&NZ and this should facilitate further growth. Positive organic growth would increase investor confidence, though the broker itself prefers to remain cautious.

Only minimal changes have been made to forecasts. Valuation drops to $8.50 from $9. Buy.

FORECAST
UBS forecasts a full year FY24 EPS of 44.00 cents.
UBS forecasts a full year FY25 EPS of 47.00 cents.

Morgan Stanley

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

IPH STOCK CHART